152 related articles for article (PubMed ID: 30745397)
1. Efficacy and Improved Resistance Potential of a Cofactor-Independent InhA Inhibitor of Mycobacterium tuberculosis in the C3HeB/FeJ Mouse Model.
Robertson GT; Ektnitphong VA; Scherman MS; McNeil MB; Dennison D; Korkegian A; Smith AJ; Halladay J; Carter DS; Xia Y; Zhou Y; Choi W; Berry PW; Mao W; Hernandez V; Alley MRK; Parish T; Lenaerts AJ
Antimicrob Agents Chemother; 2019 Apr; 63(4):. PubMed ID: 30745397
[TBL] [Abstract][Full Text] [Related]
2. Selective Inactivity of Pyrazinamide against Tuberculosis in C3HeB/FeJ Mice Is Best Explained by Neutral pH of Caseum.
Lanoix JP; Ioerger T; Ormond A; Kaya F; Sacchettini J; Dartois V; Nuermberger E
Antimicrob Agents Chemother; 2016 Feb; 60(2):735-43. PubMed ID: 26574016
[TBL] [Abstract][Full Text] [Related]
3. Heterogeneous disease progression and treatment response in a C3HeB/FeJ mouse model of tuberculosis.
Lanoix JP; Lenaerts AJ; Nuermberger EL
Dis Model Mech; 2015 Jun; 8(6):603-10. PubMed ID: 26035868
[TBL] [Abstract][Full Text] [Related]
4. Sterilizing Activity of Pyrazinamide in Combination with First-Line Drugs in a C3HeB/FeJ Mouse Model of Tuberculosis.
Lanoix JP; Betoudji F; Nuermberger E
Antimicrob Agents Chemother; 2016 Feb; 60(2):1091-6. PubMed ID: 26643352
[TBL] [Abstract][Full Text] [Related]
5. Drug distribution and efficacy of the DprE1 inhibitor BTZ-043 in the C3HeB/FeJ mouse tuberculosis model.
Ramey ME; Kaya F; Bauman AA; Massoudi LM; Sarathy JP; Zimmerman MD; Scott DWL; Job AM; Miller-Dawson JA; Podell BK; Lyons MA; Dartois V; Lenaerts AJ; Robertson GT
Antimicrob Agents Chemother; 2023 Nov; 67(11):e0059723. PubMed ID: 37791784
[TBL] [Abstract][Full Text] [Related]
6. PA-824 is as effective as isoniazid against latent tuberculosis infection in C3HeB/FeJ mice.
Dutta NK; Karakousis PC
Int J Antimicrob Agents; 2014 Dec; 44(6):564-6. PubMed ID: 25270632
[TBL] [Abstract][Full Text] [Related]
7. Mouse model of necrotic tuberculosis granulomas develops hypoxic lesions.
Harper J; Skerry C; Davis SL; Tasneen R; Weir M; Kramnik I; Bishai WR; Pomper MG; Nuermberger EL; Jain SK
J Infect Dis; 2012 Feb; 205(4):595-602. PubMed ID: 22198962
[TBL] [Abstract][Full Text] [Related]
8. In vitro and in vivo activity of clofazimine against Mycobacterium tuberculosis persisters.
Xu J; Lu Y; Fu L; Zhu H; Wang B; Mdluli K; Upton AM; Jin H; Zheng M; Zhao W; Li P
Int J Tuberc Lung Dis; 2012 Aug; 16(8):1119-25. PubMed ID: 22691726
[TBL] [Abstract][Full Text] [Related]
9. Fighting tuberculosis by drugs targeting nonreplicating
Iacobino A; Piccaro G; Giannoni F; Mustazzolu A; Fattorini L
Int J Mycobacteriol; 2017; 6(3):213-221. PubMed ID: 28776518
[TBL] [Abstract][Full Text] [Related]
10. Development of modern InhA inhibitors to combat drug resistant strains of Mycobacterium tuberculosis.
Tonge PJ; Kisker C; Slayden RA
Curr Top Med Chem; 2007; 7(5):489-98. PubMed ID: 17346194
[TBL] [Abstract][Full Text] [Related]
11. Presence of multiple lesion types with vastly different microenvironments in C3HeB/FeJ mice following aerosol infection with Mycobacterium tuberculosis.
Irwin SM; Driver E; Lyon E; Schrupp C; Ryan G; Gonzalez-Juarrero M; Basaraba RJ; Nuermberger EL; Lenaerts AJ
Dis Model Mech; 2015 Jun; 8(6):591-602. PubMed ID: 26035867
[TBL] [Abstract][Full Text] [Related]
12. Phenotypic isoniazid resistance and associated mutations in pediatric tuberculosis.
Jhanjhria S; Kashyap B; Gomber S; Gupta N; Hyanki P; Singh NP; Khanna A; Sharma AK
Indian J Tuberc; 2019 Oct; 66(4):474-479. PubMed ID: 31813434
[TBL] [Abstract][Full Text] [Related]
13. InhA inhibitors have activity against non-replicating Mycobacterium tuberculosis.
Flint L; Korkegian A; Parish T
PLoS One; 2020; 15(11):e0239354. PubMed ID: 33201882
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of a mouse model of necrotic granuloma formation using C3HeB/FeJ mice for testing of drugs against Mycobacterium tuberculosis.
Driver ER; Ryan GJ; Hoff DR; Irwin SM; Basaraba RJ; Kramnik I; Lenaerts AJ
Antimicrob Agents Chemother; 2012 Jun; 56(6):3181-95. PubMed ID: 22470120
[TBL] [Abstract][Full Text] [Related]
15. Limited activity of clofazimine as a single drug in a mouse model of tuberculosis exhibiting caseous necrotic granulomas.
Irwin SM; Gruppo V; Brooks E; Gilliland J; Scherman M; Reichlen MJ; Leistikow R; Kramnik I; Nuermberger EL; Voskuil MI; Lenaerts AJ
Antimicrob Agents Chemother; 2014 Jul; 58(7):4026-34. PubMed ID: 24798275
[TBL] [Abstract][Full Text] [Related]
16. Differential Mycobacterium bovis BCG vaccine-derived efficacy in C3Heb/FeJ and C3H/HeOuJ mice exposed to a clinical strain of Mycobacterium tuberculosis.
Henao-Tamayo M; Obregón-Henao A; Creissen E; Shanley C; Orme I; Ordway DJ
Clin Vaccine Immunol; 2015 Jan; 22(1):91-8. PubMed ID: 25392011
[TBL] [Abstract][Full Text] [Related]
17. [The characteristics of the sensitivity of Mycobacterium tuberculosis to rifampicin and isoniazid through determination of mutations in the genes rpoB, katG, inhA, oxyR, and kasA by different molecular biological assays].
Skotnikova OI; Galkina KIu; Nosova EIu; Krasnova MA; Moroz AM
Probl Tuberk Bolezn Legk; 2005; (8):42-5. PubMed ID: 16209020
[TBL] [Abstract][Full Text] [Related]
18. Discovery of a cofactor-independent inhibitor of
Xia Y; Zhou Y; Carter DS; McNeil MB; Choi W; Halladay J; Berry PW; Mao W; Hernandez V; O'Malley T; Korkegian A; Sunde B; Flint L; Woolhiser LK; Scherman MS; Gruppo V; Hastings C; Robertson GT; Ioerger TR; Sacchettini J; Tonge PJ; Lenaerts AJ; Parish T; Alley M
Life Sci Alliance; 2018 Jun; 1(3):e201800025. PubMed ID: 30456352
[TBL] [Abstract][Full Text] [Related]
19. Evaluation of Berberine as an Adjunct to TB Treatment.
Ozturk M; Chia JE; Hazra R; Saqib M; Maine RA; Guler R; Suzuki H; Mishra BB; Brombacher F; Parihar SP
Front Immunol; 2021; 12():656419. PubMed ID: 34745081
[TBL] [Abstract][Full Text] [Related]
20. Therapeutic Potential of the Mycobacterium tuberculosis Mycolic Acid Transporter, MmpL3.
Li W; Obregón-Henao A; Wallach JB; North EJ; Lee RE; Gonzalez-Juarrero M; Schnappinger D; Jackson M
Antimicrob Agents Chemother; 2016 Sep; 60(9):5198-207. PubMed ID: 27297488
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
